News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
765,400 Results
Type
Article (45883)
Company Profile (307)
Press Release (719186)
Multimedia
Podcasts (136)
Webinars (28)
Section
Business (214651)
Career Advice (2240)
Deals (37157)
Drug Delivery (147)
Drug Development (84023)
Employer Resources (180)
FDA (17424)
Job Trends (15757)
News (362989)
Policy (34840)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (5)
Academia (2747)
Accelerated approval (46)
Adcomms (29)
Allergies (180)
Alliances (52865)
ALS (212)
Alzheimer's disease (1828)
Antibody-drug conjugate (ADC) (449)
Approvals (17775)
Artificial intelligence (699)
Autoimmune disease (277)
Automation (54)
Bankruptcy (373)
Best Places to Work (12087)
BIOSECURE Act (20)
Biosimilars (229)
Biotechnology (194)
Bladder cancer (188)
Brain cancer (72)
Breast cancer (750)
Cancer (5863)
Cardiovascular disease (472)
Career advice (1901)
Career pathing (41)
CAR-T (341)
CDC (65)
Celiac Disease (3)
Cell therapy (921)
Cervical cancer (46)
Clinical research (72600)
Collaboration (2154)
Company closure (5)
Compensation (1378)
Complete response letters (82)
COVID-19 (2860)
CRISPR (115)
C-suite (1133)
Cystic fibrosis (153)
Data (7746)
Decentralized trials (3)
Denatured (42)
Depression (170)
Dermatology (81)
Diabetes (602)
Diagnostics (7203)
Digital health (56)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (324)
Drug pricing (223)
Drug shortages (35)
Duchenne muscular dystrophy (288)
Earnings (94645)
Editorial (67)
Employer branding (21)
Employer resources (157)
Events (124754)
Executive appointments (1117)
FDA (21181)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (34)
Funding (1762)
Gene editing (242)
Generative AI (57)
Gene therapy (754)
GLP-1 (1137)
Government (5015)
Grass and pollen (8)
Guidances (408)
Healthcare (19783)
HIV (80)
Huntington's disease (58)
IgA nephropathy (97)
Immunology and inflammation (300)
Immuno-oncology (94)
Indications (180)
Infectious disease (3211)
Inflammatory bowel disease (221)
Inflation Reduction Act (14)
Influenza (141)
Intellectual property (295)
Interviews (350)
IPO (17181)
IRA (55)
Job creations (3994)
Job search strategy (1589)
JPM (64)
Kidney cancer (19)
Labor market (97)
Layoffs (601)
Leadership (37)
Legal (8462)
Liver cancer (104)
Longevity (34)
Lung cancer (770)
Lymphoma (426)
Machine learning (61)
Management (63)
Manufacturing (1078)
MASH (187)
Medical device (14755)
Medtech (14866)
Mergers & acquisitions (21228)
Metabolic disorders (1558)
mRNA (212)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (431)
Neuropsychiatric disorders (111)
Neuroscience (3369)
Neurotech (1)
NextGen: Class of 2026 (6888)
Non-profit (4685)
Now hiring (76)
Obesity (744)
Opinion (320)
Ovarian cancer (215)
Pain (257)
Pancreatic cancer (297)
Parkinson's disease (369)
Partnered (34)
Patents (602)
Patient recruitment (675)
Peanut (65)
People (62174)
Pharmaceutical (72)
Pharmacy benefit managers (33)
Phase 1 (22703)
Phase 2 (31921)
Phase 3 (23792)
Pipeline (8261)
Policy (340)
Postmarket research (2645)
Preclinical (9653)
Press Release (71)
Prostate cancer (301)
Psychedelics (59)
Radiopharmaceuticals (333)
Rare diseases (1099)
Real estate (6430)
Recruiting (71)
Regulatory (26862)
Reports (57)
Research institute (2538)
Resumes & cover letters (376)
Rett syndrome (37)
RNA editing (21)
RSV (92)
Schizophrenia (180)
Series A (300)
Series B (218)
Service/supplier (14)
Sickle cell disease (115)
Special edition (25)
Spinal muscular atrophy (172)
Sponsored (51)
Startups (3891)
State (2)
Stomach cancer (18)
Supply chain (132)
Tariffs (97)
The Weekly (91)
Vaccines (1162)
Venture capital (112)
Weight loss (493)
Women's health (125)
Worklife (21)
Date
Today (181)
Last 7 days (847)
Last 30 days (3229)
Last 365 days (31391)
2026 (11570)
2025 (31195)
2024 (36338)
2023 (41350)
2022 (52594)
2021 (57333)
2020 (55973)
2019 (48880)
2018 (36892)
2017 (33914)
2016 (33512)
2015 (39625)
2014 (33165)
2013 (28323)
2012 (30553)
2011 (31179)
2010 (28943)
Location
Africa (813)
Alabama (92)
Alaska (7)
Arizona (360)
Arkansas (15)
Asia (43267)
Australia (7114)
California (13170)
Canada (3743)
China (1377)
Colorado (568)
Connecticut (577)
Delaware (405)
Europe (95308)
Florida (1958)
Georgia (429)
Hawaii (4)
Idaho (66)
Illinois (1086)
India (92)
Indiana (618)
Iowa (24)
Japan (532)
Kansas (137)
Kentucky (53)
Louisiana (43)
Maine (87)
Maryland (1600)
Massachusetts (9465)
Michigan (384)
Minnesota (724)
Mississippi (7)
Missouri (157)
Montana (36)
Nebraska (29)
Nevada (144)
New Hampshire (89)
New Jersey (3505)
New Mexico (31)
New York (3445)
North Carolina (1721)
North Dakota (10)
Northern California (6592)
Ohio (402)
Oklahoma (25)
Oregon (46)
Pennsylvania (2644)
Puerto Rico (29)
Rhode Island (50)
South America (1228)
South Carolina (87)
South Dakota (2)
Southern California (5161)
Tennessee (210)
Texas (2106)
United States (46875)
Utah (398)
Vermont (1)
Virginia (332)
Washington D.C. (82)
Washington State (1072)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
765,400 Results for "maxim integrated products inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NovaBridge Appoints Mark Hagler as President and Chief Commercial Officer to Advance Commercial Strategy and Maximize Pipeline Value
April 22, 2026
·
8 min read
Press Releases
ENDRA Life Sciences Initiates Review of Strategic Alternatives to Maximize Shareholder Value
March 25, 2026
·
5 min read
Press Releases
Aethlon Medical Engages Maxim Group LLC to Evaluate Strategic Opportunities
March 12, 2026
·
5 min read
Sponsored by Curium
From Product to Patient in Nuclear Medicine: Why Vertical Integration Is Essential for a Competitive Advantage
In nuclear medicine, innovation alone isn’t enough. What matters is whether it can be delivered on time, every time, because timing is critical for our patients. And that delivery promise must hold up under real-world pressure – from routine variability to sudden disruptions that can reroute global logistics overnight.
April 20, 2026
·
4 min read
·
Renaud Dehareng, CEO, Curium
Press Releases
Co-Diagnostics, Inc. to Attend 2025 Maxim Growth Summit
October 14, 2025
·
2 min read
Press Releases
Gilead Sciences to Acquire Arcellx to Maximize Long-Term Potential of Anito-cel
February 23, 2026
·
12 min read
Press Releases
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2026
April 23, 2026
·
17 min read
Press Releases
Gain Therapeutics to Attend the 2025 Maxim Growth Summit
October 17, 2025
·
4 min read
Press Releases
BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
October 16, 2025
·
4 min read
Press Releases
HCW Biologics to Participate in the 2025 Maxim Growth Summit
October 17, 2025
·
4 min read
1 of 76,540
Next
